Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context

While the initial treatment of non-small cell lung cancer (NSCLC) usually relies on surgical resection followed by systemic cytotoxic chemotherapy and/or radiation therapy, recent advances in understanding of NSCLC biology and immunology have spurred the development of numerous targeted therapies. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Alexander D, Alzghari, Saeed K, Jean, Gary W, La-Beck, Ninh M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328134/
https://www.ncbi.nlm.nih.gov/pubmed/28260909
http://dx.doi.org/10.2147/TCRM.S104343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328134/
https://www.ncbi.nlm.nih.gov/pubmed/28260909
http://dx.doi.org/10.2147/TCRM.S104343

Ejemplares similares